Clinical Report: Dry Eye Updates Highlight Diagnostic Precision and Tailored Care
Overview
At the 2025 Optometric Management Symposium, Dr. Nona Kalfayan emphasized the importance of accurate diagnosis and a stepwise approach in managing dry eye disease (DED). The integration of validated surveys and objective diagnostic tools is crucial for effective treatment selection.
Background
Dry eye disease is a multifaceted condition that poses significant challenges in diagnosis and management due to its variable presentation. Accurate identification of the type of DED is essential for tailoring treatment to individual patient needs. Recent advancements in diagnostic tools and treatment protocols aim to enhance clinical outcomes and patient satisfaction.
Data Highlights
No numerical data provided in the source material.
Key Findings
['Accurate diagnosis of DED requires a combination of validated patient surveys and objective diagnostic tools.', 'First-line management includes patient education, lifestyle modifications, lid hygiene, and artificial tears.', 'Topical anti-inflammatories are recommended for patients with persistent symptoms, while corticosteroids are reserved for acute flares.', 'Advanced interventions, such as autologous serum tears and amniotic membrane grafts, may be necessary for severe cases.', 'Evidence-based algorithms, such as those from the Tear Film & Ocular Surface Society, can guide treatment selection.']Clinical Implications
Clinicians should adopt a stepwise approach to DED management, utilizing both subjective and objective assessment tools to tailor treatment. Following evidence-based protocols can simplify decision-making and enhance patient care.
Conclusion
The integration of precise diagnostic methods and tailored treatment strategies is essential for effective management of dry eye disease. By focusing on individual patient needs, clinicians can improve outcomes and provide lasting relief.
References
- Ophthalmology Management, 2014 -- How new diagnostics help us tame the beast of dry eye
- Optometric Management, 2023 -- CLINICAL: Dry Eye Recommendations
- contact lens spectrum, 2025 -- Dry Eye Dx and Tx: Tech’s Role in Modern Dry Eye Diagnostics
- optometric management, 2025 -- Getting Ahead of Dry Eye
- TFOS DEWS III: Management and Therapy - ScienceDirect
- TFOS DEWS III: Management and Therapy - ScienceDirect
- TFOS DEWS III 管理与治疗报告
- Efficacy and safety of perfluorohexyloctane (PFHO) in patients with dry eye disease (DED) due to meibomian gland dysfunction (MGD): Systematic review and meta-analysis - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


